Novo Nordisk | NVO - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
ANI Pharmaceuticals USD 562.3M 344.37M 2026-03
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Bausch Health Companies USD 2.08B 41M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 98.72M 11.51M 2026-03
Corcept Therapeutics USD 214.85M 343K 2026-06
Drreddys Laboratories INR 74.33B 1.4B 2026-03
Eli Lilly USD 10.02B 285M 2026-03
GlaxoSmithKline GBP 5.8B 468M 2026-06
Merck USD 18.17B 8.01B 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Novartis USD 10.2B 912M 2026-06
Novo Nordisk DKK 37.21B 9.56B 2026-03
Novo Nordisk DKK 6.5B 32.8B 2025-06
Pacira USD 172.75M 20.93M 2026-03
Perrigo USD 935.6M 89.6M 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 206.12M 5.17M 2026-03
Sanofi EUR 9.92B 607M 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Zoetis USD 3.23B 1.68B 2026-03